BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2026.
World J Psychiatry. Feb 19, 2026; 16(2): 112819
Published online Feb 19, 2026. doi: 10.5498/wjp.v16.i2.112819
Table 1 Comparison of baseline characteristics between the two groups, n (%)
Characteristics
Electroencephalogram group (n = 118)
Control group (n = 122)
Statistical value
P value
Demographic characteristics
Age (years) (mean ± SD)72.3 ± 5.771.8 ± 6.1t = 0.6420.521
Genderχ² = 0.0390.843
Male75 (63.6)79 (64.8)
Female43 (36.4)43 (35.2)
Body mass index (kg/m²) (mean ± SD)23.5 ± 2.823.2 ± 3.0t = 0.7790.437
Clinical characteristics
American Society of Anesthesiologists classificationχ² = 0.4150.520
Grade II72 (61.0)69 (56.6)
Grade III46 (39.0)53 (43.4)
Comorbidities
Hypertension55 (46.6)59 (48.4)χ² = 0.0740.786
Diabetes36 (30.5)40 (32.8)χ² = 0.1460.702
Coronary heart disease26 (22.0)30 (24.6)χ² = 0.2210.639
Preoperative laboratory tests
Hemoglobin (g/L) (mean ± SD)118.5 ± 13.2116.8 ± 14.5t = 0.9460.345
Albumin (g/L) (mean ± SD)36.8 ± 3.537.2 ± 3.3t = -0.8970.371
Tumor characteristics
TNM stagingχ² = 0.3780.828
Stage I32 (27.1)30 (24.6)
Stage II51 (43.2)53 (43.4)
Stage III35 (29.7)39 (32.0)
Tumor locationχ² = 0.2670.875
Cardia28 (23.7)31 (25.4)
Body45 (38.1)43 (35.2)
Antrum45 (38.1)48 (39.3)
Differentiation degreeχ² = 0.1990.905
Well differentiated21 (17.8)19 (15.6)
Moderately differentiated62 (52.5)66 (54.1)
Poorly differentiated35 (29.7)37 (30.3)
Surgery-related
Surgical approachχ² = 0.0180.892
Open69 (58.5)72 (59.0)
Laparoscopic49 (41.5)50 (41.0)
Preoperative assessment
PSQI total score (mean ± SD)9.8 ± 2.610.1 ± 2.4t = -0.9040.367
PSQI component scores (mean ± SD)
Sleep quality1.8 ± 0.61.9 ± 0.5t = -0.8230.411
Sleep latency1.7 ± 0.71.8 ± 0.6t = -0.7360.463
Sleep duration1.6 ± 0.51.7 ± 0.6t = -0.8710.385
Sleep efficiency1.5 ± 0.61.6 ± 0.5t = -0.8020.424
Sleep disturbances1.9 ± 0.41.8 ± 0.5t = 0.6450.520
Use of sleep medication0.5 ± 0.80.6 ± 0.7t = -0.6000.549
Daytime dysfunction1.7 ± 0.61.8 ± 0.5t = -0.8510.395
HADS scores (mean ± SD)
Anxiety subscale (HADS-A)5.8 ± 1.95.7 ± 2.0t = 0.4010.689
Depression subscale (HADS-D)6.0 ± 1.85.9 ± 1.7t = 0.4440.657
Table 2 Multivariate analysis results for postoperative psychological outcomes
Variable
Odds ratio
95%CI
P value
Protective factors
Electroencephalogram-guided individualized anesthesia0.560.41-0.780.003
Reasonable preoperative psychological preparation0.650.45-0.940.022
Good postoperative pain control (resting Visual Analog Scale < 4)0.740.53-1.020.067
Risk factors
Preoperative psychological factors
Preoperative Hospital Anxiety and Depression Scale score ≥ 82.151.42-3.26< 0.001
Preoperative PSQI score ≥ 101.871.26-2.780.002
Individual PSQI components
Poor sleep efficiency (≤ 75%)2.241.48-3.39< 0.001
Frequent sleep disturbances (≥ 2.5 points)1.951.32-2.880.001
Patient-related factors
Age ≥ 75 years1.431.02-2.010.038
American Society of Anesthesiologists III1.390.97-1.980.072
Intraoperative factors
Intraoperative hypotension1.751.18-2.610.006
Operation time > 3 hours1.681.13-2.490.010
Intraoperative blood loss > 300 mL1.521.06-2.170.021
Intraoperative temperature < 36.0 °C1.461.05-2.030.024
Table 3 Gradient effect of electroencephalogram-guided anesthesia on postoperative psychological outcomes across sleep disorder severity spectrum, mean ± SD
Sleep disorder severity
Measure
Electroencephalogram group
Control group
t value
P value
SevereHADS-A5.9 ± 1.88.6 ± 2.1-5.32< 0.001
HADS-D6.4 ± 1.68.2 ± 1.9-4.06< 0.001
HADS total12.3 ± 3.116.8 ± 3.4-5.48< 0.001
ModerateHADS total10.7 ± 2.914.2 ± 3.2-5.67< 0.001
MildHADS-A4.5 ± 1.75.3 ± 1.9-2.040.045
HADS-D5.0 ± 1.56.4 ± 1.7-4.03< 0.001
HADS total9.5 ± 2.611.7 ± 2.8-3.640.023
Table 4 Comparison of postoperative complications and recovery between electroencephalogram and control groups, n (%)
Outcome
Electroencephalogram group (n = 118)
Control group (n = 122)
Statistic
P value
Postoperative complications
Overall complication rate38 (32.2)59 (48.4)χ² = 6.720.010
Postoperative delirium10 (8.5)21 (17.2)χ² = 4.310.038
Duration of delirium (days) (mean ± SD)1.7 ± 0.62.5 ± 0.9t = -2.620.014
Postoperative nausea and vomiting30 (25.4)46 (37.7)χ² = 4.270.039
Number of vomiting episodes (mean ± SD)1.3 ± 0.62.2 ± 1.0t = -5.05< 0.001
Perioperative hypotension16 (13.6)30 (24.6)χ² = 4.850.028
Pulmonary infection6 (5.1)15 (12.3)χ² = 3.920.048
Wound infection7 (5.9)9 (7.4)χ² = 0.190.659
Urinary tract infection4 (3.4)7 (5.7)χ² = 0.760.384
Pain management
POD1 VAS score (at rest) (mean ± SD)3.2 ± 1.13.9 ± 1.3t = -4.65< 0.001
POD1 VAS score (with movement) (mean ± SD)5.1 ± 1.45.8 ± 1.5t = -3.73< 0.001
POD2 VAS score (at rest) (mean ± SD)2.5 ± 0.93.0 ± 1.1t = -3.89< 0.001
POD2 VAS score (with movement) (mean ± SD)4.2 ± 1.34.9 ± 1.4t = -4.02< 0.001
POD3 VAS score (at rest) (mean ± SD)1.9 ± 0.82.3 ± 1.0t = -3.460.001
POD3 VAS score (with movement) (mean ± SD)3.6 ± 1.14.1 ± 1.2t = -3.340.001
Cumulative analgesic consumption (morphine equivalent mg) (mean ± SD)45.3 ± 12.858.7 ± 16.2t = -7.24< 0.001
Gastrointestinal recovery
Time to first bowel sounds (hours) (mean ± SD)46.5 ± 12.853.2 ± 14.5t = -3.82< 0.001
Time to first flatus (hours) (mean ± SD)62.3 ± 15.670.8 ± 16.9t = -4.04< 0.001
Time to first liquid diet (days) (mean ± SD)3.5 ± 1.24.3 ± 1.5t = -4.53< 0.001
Early ambulation
Time to first out-of-bed activity (hours) (mean ± SD)26.8 ± 7.632.5 ± 9.2t = -5.21< 0.001
6-minute walking test on POD3 (m) (mean ± SD)152.6 ± 45.8128.3 ± 40.6t = 4.28< 0.001
Hospitalization outcomes
Total length of stay (days) (mean ± SD)12.6 ± 3.214.8 ± 3.5t = -5.050.012
Postoperative length of stay (days) (mean ± SD)10.8 ± 2.712.5 ± 3.0t = -4.58< 0.001
30-day readmission rate4 (3.4)8 (6.6)χ² = 1.290.256